Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target 2023-11-29 04:01
Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award 2023-11-28 21:30
Akeso Launches Construction of Shanghai Global R&D Center to Accelerate Its Innovation Globalization Strategy 2023-11-28 21:00
Angel Yeast Brings Sustainable Food Solutions for the Future to FI Europe & Hi 2023 2023-11-28 20:00
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization 2023-11-28 19:00
L'Oréal-UNESCO For Women in Science 2023 Supports Three Promising Researchers from Singapore in the fields of Material Engineering, Biotechnology, and Sustainable Chemistry 2023-11-28 14:17
RemeGen Announces Publication of Results from Two Phase II Studies for Disitamab Vedotin in Latest Issue of Journal of Clinical Oncology (JCO) 2023-11-28 09:48
AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology 2023-11-27 22:05
Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients 2023-11-27 21:30
XtalPi and HKU's Advanced Biomedical Instrumentation Centre Sign MoU to Accelerate Deep Tech Commercialization 2023-11-27 21:20
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia 2023-11-24 22:00
Ascentage Pharma Hosts Ceremony Marking the Launch of Olverembatinib in Newly Approved Indication and the Dispatch of First Batch for the New Indication 2023-11-24 19:57
China's First NDA for a KRAS G12C Inhibitor: NMPA Accepts New Drug Application for GFH925 and Grants GFH925 with Priority Review Designation 2023-11-24 19:00
Everest Medicines Announces China NMPA's Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients 2023-11-24 12:54
China's First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351 2023-11-24 08:42
Medica 2023: Fapon Accelerates the Development of its Diagnostic Ecosystem 2023-11-23 17:27
Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart 2023-11-23 16:04
IASO Bio establishes international CAR-T diagnostic and treatment center in China to serve MM patients worldwide 2023-11-23 15:17
PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome 2023-11-23 10:31
Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Accepted the New Drug Application for Taletrectinib (ROS1 Inhibitor) 2023-11-23 08:00
1 66 67 68 69 70 451